Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. (Q53803725)

19 May 2018

title

Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. (English)

1 reference

19 May 2018

main subject

arterial hypertension

0 references

author name string

Vaughan ED Jr

1

1 reference

19 May 2018

Laragh JH

2

1 reference

19 May 2018

Gavras I

3

1 reference

19 May 2018

Bühler FR

4

1 reference

19 May 2018

Gavras H

5

1 reference

19 May 2018

Brunner HR

6

1 reference

19 May 2018

Baer L

7

1 reference

19 May 2018

language of work or name

English

0 references

publication date

1 September 1973

1 reference

19 May 2018

American Journal of Cardiology

published in

1 reference

19 May 2018

volume

32

1 reference

19 May 2018

issue

4

1 reference

19 May 2018

page(s)

523-532

1 reference

19 May 2018

Essential hypertension: renin and aldosterone, heart attack and stroke.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of Spironolactone in Hypertensive Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hypertension and Low Plasma Renin Activity: Presumptive Evidence for Mineralocorticoid Excess

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hyporeninemic hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Apparently isolated excess deoxycorticosterone in hypertension. A variant of the mineralocorticoid-excess syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Metabolic Studies on Hypertensive Patients with Suppressed Plasma Renin Activity Not Due to Hyperaldosteronism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The control of aldosterone secretion in normal and hypertensive man: abnormal renin-aldosterone patterns in low renin hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The renin system: Variations in man measured by radioimmunoassay or bioassay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Aldosterone excretion. Physiological variations in man measured by radioimmunoassay or double-isotope dilution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Potassium balance and the control of renin secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

The effects of spironolactone and chlorthalidone on arterial pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Treatment of arterial hypertensive disease with diuretics. V. Spironolactone, an aldosterone antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Comparative Studies on Spironolactone (Aldactone) and Chlorthalidone (Hygroton) in the Treatment of Arterial Hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Relationship between plasma and extracellular fluid volume depletion and the antihypertensive effect of chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Changes in Plasma and Extracellular Fluid Volumes in Patients with Essential Hypertension During Long-Term Treatment with Hydrochlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Long-term thiazide therapy in essential hypertension. Evidence for persistent alteration in plasma volume and renin activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Why Do Thiazide Diuretics Lower Blood Pressure in Essential Hypertension?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Mechanism of the altered blood pressure responsiveness produced by chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of chlorothiazide and sodium on vascular responsiveness to angiotensin II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Chlorothiazide in hypertension: studies on its mode of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Hemodynamic and hypotensive effects of long-term therapy with chlorothiazide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Effect of thiazide diuretics on plasma volume, body electrolytes, and excretion of aldosterone in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Renin-angiotensin-aldosterone system during chronic thiazide therapy of benign hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2873%2980044-X

10.1016/S0002-9149(73)80044-X

7 January 2021

Identifiers

DOI

1 reference

19 May 2018

1 reference

19 May 2018